Our Commitment To Global Health: Why, What, and How  

Speaker: Prof. Fujie Xu

Deputy Director of Health

China Country Office

Bill & Melinda Gates Foundation

Date: Tuesday Jan 16, 2024.

Time: 9:00 – 10:00 AM (Beijing Time)

Venue: IB1010

& Zoom ID: 715 337 7467

Passcode: dku

Title:

Our Commitment To Global Health: Why, What, and How  

Biography:

Fujie joined the foundation in May 2020, as the Deputy Director of Health, China Country Office. As an infectious disease physician and an epidemiologist, Fujie heads the health team in developing innovations ranging from basic biomedical science to regulatory science, and in implementing evidence[1] based service delivery to systematically advance the control of HIV, TB, malaria, and vaccine preventable diseases.

Fujie has studied and worked in both the United States and in China. Most recently she was a professor of infectious disease epidemiology doing research on viral hepatitis. Fujie’s career has taken her from the public sector in the United States at the Centers for Disease Control and Prevention, to the private sector at Gilead Science Inc., and to academics at Zhejiang University in China. She brings more than 20 years of experience in public health research and program, with a focus on infectious diseases. She holds a PhD in epidemiology from Emory University and earned her medical degree from Peking University Health Science Center. Her entry to global health work started in Thailand when she was an

Epidemic Intelligence Service (EIS) officer trained to be a ready responder, also known as CDC’s disease detective.

Seminar abstract:

Before the losses of lives and livelihoods caused by COVID-19 fade in people’s memory, the global health community should come together to reflect on the many lessons, to renew our commitments to health equity and security, and to build the post-pandemic consensuses about international cooperation and collaboration.  In this lecture, professor Fujie Xu, an infectious disease epidemiologist from the Bill and Melinda Gates Foundation, will discuss these critical topics, and the why, the what and the how of global health.  She will also reflect on her personal journey to global health with experiences of responding to health emergencies, directing global access programs, and conducting public health research. Finally, she will give an overview of health innovations in the research and development pipeline that promise to be cheaper, more effective, and easier to deliver, harnessing advances in science and technology.